A new formulation of erythromycin stearate: blood and sputum levels in patients with chronic lower respiratory tract infection

作者：C. W. CLARKE, CS May, William Allen Robinson, Peter A. Hampshire, B. D. Rawal · 发表于：Journal of Antimicrobial Chemotherapy · 年份：1980 · DOI：10.1093/jac/6.3.389 · 被引用次数：9 · 研究领域：Respiratory and Cough-Related Research、Pneumonia and Respiratory Infections、Asthma and respiratory diseases

Blood and sputum levels of erythromycin have been measured in six patients with chronic lower respiratory tract infection after treatment with a new formulation of erythromycin stearate (Abbott Laboratories; C946) in doses of 500 mg tds. Blood erythromycin levels were generally higher than those reported for other erythromycin preparations, but sputum levels were poor.